Advances in emerging therapies 2009.
McArthur
Kate
K
Acute Stroke Unit, University Department of Medicine and Therapeutics, Gardiner Institute, Western Infirmary and Faculty of Medicine, University of Glasgow, Glasgow, UK. k.mcarthur@clinmed.gla.ac.uk
Lees
Kennedy R
KR
D000889:Anti-Arrhythmia Agents / Q000494:pharmacology / Q000627:therapeutic use; D000925:Anticoagulants / Q000494:pharmacology* / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000150:complications* / Q000188:drug therapy; D002986:Clinical Trials as Topic / Q000706:statistics & numerical data; D005343:Fibrinolytic Agents / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use; D020767:Intracranial Thrombosis / Q000188:drug therapy / Q000503:physiopathology / Q000517:prevention & control; D020521:Stroke / Q000175:diagnosis / Q000188:drug therapy* / Q000517:prevention & control*; D017131:Thrombectomy / Q000379:methods / Q000639:trends; D057170:Translational Research, Biomedical / Q000379:methods / Q000639:trends
D000889:Anti-Arrhythmia Agents; D000925:Anticoagulants; D005343:Fibrinolytic Agents; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors